文献速递免疫规划传染病防控与疫情报告

一项III期观察者盲法随机对照研究:评估大学生接种四价ACWY脑膜炎球菌多糖结合疫苗或B群脑膜炎球菌疫苗后的免疫应答及其与鼻咽部携带的相关性

A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine.
PubMed 文献 · Vaccine · 2016-11-29

本研究在大学生中评估两剂4CMenB或一剂MenACWY-CRM的免疫原性,于首剂后第2、4、6、12个月检测hSBA滴度并分析其与鼻咽部携带的相关性。结果显示两种疫苗均诱导强劲功能性抗体应答,但接种后hSBA滴度与疾病相关血清群携带之间未观察到显著相关性。

要点

  • 大学生接种4CMenB或MenACWY-CRM后第2个月均产生强劲功能性抗体应答,至第12个月仍维持较高比例的保护性hSBA滴度。
  • 基线时,已具有保护性hSBA滴度的受试者中疾病相关B群及C、Y群菌株携带率更高。
  • 接种后hSBA滴度与疾病相关血清群携带之间未观察到显著相关性。

核心结论

  • 4CMenB和MenACWY-CRM均具有高度免疫原性,但携带与接种后hSBA滴度之间无相关性。

研究设计与样本

  • III期观察者盲法随机对照研究,在大学学生中评估两剂4CMenB或一剂MenACWY-CRM的免疫原性,并于首剂后第2、4、6、12个月检测hSBA滴度。
  • 同时评估既往接种过脑膜炎球菌C群结合疫苗的学生接种一剂MenACWY-CRM的免疫原性。
  • 采用人补体杀菌抗体(hSBA)试验检测针对B群三个参考菌株及C群和Y群各一个菌株的抗体应答。
  • 分析hSBA滴度与脑膜炎球菌携带之间的相关性。

主要发现

  • 所有受试者在第2个月对两种疫苗均表现出强劲的功能性抗体应答,且较高比例维持保护性hSBA滴度至第12个月。
  • 基线时,疾病相关B群菌株及C群和Y群的携带在已具有保护性hSBA滴度的受试者中更高。
  • 接种后,4CMenB和MenACWY-CRM均在学生中诱导强劲免疫原性,但未观察到接种后hSBA滴度与疾病相关血清群携带之间的显著相关性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: University students have high rates of pharyngeal carriage of Neisseria meningitidis. Interruption of carriage acquisition is an important mechanism of vaccines for inducing herd protection. 4CMenB and MenACWY-CRM vaccines have been shown to be immunogenic against meningococcal serogroups B and ACWY respectively in younger age groups, and also to elicit a modest impact on meningococcal carriage in vaccinated students. However, vaccine responses in university students and the impact of serum bactericidal antibody (SBA) titers on meningococcal carriage are undetermined. METHODS: Immunogenicity of two 4CMenB doses or one MenACWY-CRM dose was measured in university students at Months 2, 4, 6 and 12 post-first vaccination. Immunogenicity of one MenACWY-CRM dose in students with previous meningococcal serogroup C conjugate vaccination was also assessed. Immune responses were measured with an SBA assay using human complement (hSBA) against three reference strains for serogroup B and against one strain for each for serogroups C and Y. Correlations between hSBA titers and meningococcal carriage were analyzed. RESULTS: All subjects demonstrated robust functional antibody responses to both vaccines at Month 2 and a high proportion maintained protective hSBA titers up to Month 12. At baseline, carriage of disease-associated serogroup B strains and serogroups C and Y were higher in subjects with already-protective hSBA titers. Post-vaccination, while both 4CMenB and MenACWY-CRM elicited robust immunogenicity in students, significant correlations between post-vaccination hSBA titers and carriage of disease-associated serogroups were not observed. CONCLUSIONS: 4CMenB and MenACWY-CRM were both highly immunogenic. There was no correlation between carriage and post-vaccination hSBA titers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Read RC, Dull P, Bai X, et al. A phase III observer-blind randomized, controlled study to evaluate the immune response and the correlation with nasopharyngeal carriage after immunization of university students with a quadrivalent meningococcal ACWY glycoconjugate or serogroup B meningococcal vaccine. Vaccine. 2016. PMID: 27912986. doi:10.1016/j.vaccine.2016.11.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。